Secondary Peritonitis and Intra-Abdominal Sepsis: An Increasingly Global Disease in Search of Better Systemic Therapies. (June 2021)

• Record Type: Journal Article
• Authors: Clements, T. W.; Tolonen, M.; Ball, C. G.; Kirkpatrick, A. W.
• Is Part Of: Scandinavian journal of surgery. Volume 110:Number 2(2021)
• Page Start: 139
• Page End: 149
• Publication Date: 2021-06
• Subjects: Peritonitis -- secondary peritonitis -- intra-abdominal sepsis -- human microbiome -- pathobiome -- multiple organ dysfunction syndrome; Surgery -- Periodicals; 617.005
• DOI: 10.1177/1457496920984078
• Languages: English
• ISSNs: 1457-4969

Abstract

Secondary peritonitis and intra-abdominal sepsis are a global health problem. The life-threatening systemic insult that results from intra-abdominal sepsis has been extensively studied and remains somewhat poorly understood. While local surgical therapy for perforation of the abdominal viscera is an age-old therapy, systemic therapies to control the subsequent systemic inflammatory response are scarce. Advancements in critical care have led to improved outcomes in secondary peritonitis. The understanding of the effect of secondary peritonitis on the human microbiome is an evolving field and has yielded potential therapeutic targets. This review of secondary peritonitis discusses the history, classification, pathophysiology, diagnosis, treatment, and future directions of the management of secondary peritonitis. Ongoing clinical studies in the treatment of secondary peritonitis and the open abdomen are discussed.